Characteristics of High-Risk Patients Eligible For Venous FPG Measurement, Comparing Patients With and Without a Venous Sample
| Characteristic | Patients With Venous Sample | Patients Without Venous Sample | PValue |
|---|---|---|---|
| BMI = body mass index; FPG = fasting plasma glucose; cFPG1 = first capillary fasting plasma glucose; cFPG2 = second capillary fasting plasma glucose; GDM = gestational diabetes mellitus. | |||
| a Conversion factor to SI units: ×0.0555. | |||
| b Missing = 94 with venous sample; 30 without venous sample. | |||
| c Missing = 100 with venous sample; 26 without venous sample. | |||
| Sex (male), No. (%) | 57 (45.6) | 23 (52.3) | .45 |
| Age, mean (SD), years | 58.8 (8.0) | 58.5 (8.1) | .87 |
| cFPG measurements | |||
| cFPG1, mean (SD), mg/dLa | 156.8 (55.9) | 151.4 (50.5) | .59 |
| cFPG2, mean (SD), mg/dL | 149.5 (41.4) | 140.5 (37.8) | .23 |
| cFPG1 110–126 mg/dL and cFPG2 ≥126 mg/dL, No. (%) | 28 (22.4) | 6 (13.6) | .21 |
| cFPG1 ≥ 126 mg/dL and cFPG2 110–126 mg/dL, No. (%) | 22 (17.6) | 21 (47.8) | <.001 |
| cFPG1 ≥ 126 mg/dL and cFPG2 ≥ 126 mg/dL, No. (%) | 75 (60.0) | 17 (38.6) | .01 |
| BMI, mean (SD), kg/m2 | 30.2 (4.6) | 31.0 (6.9) | .39 |
| Risk factors | |||
| Hypertension, No. (%) | 49 (39.2) | 15 (34.1) | .55 |
| Cardiovascular disease, No. (%) | 22 (17.6) | 5 (11.4) | .33 |
| Lipid metabolism disorders,b No. (%) | 12 (38.7) | 3 (21.4) | .41 |
| Family history of diabetes, No. (%) | 58 (46.4) | 17 (38.6) | .37 |
| History of GDM,c No. (%) | 0 | 0 | – |